FSCN1 gene polymorphisms: biomarkers for the development and progression of breast cancer
2017 · Scientific Reports · 49 citations
https://doi.org/10.1038/s41598-017-16196-6
C
Chaoqun Wang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
139
Papers
3.0K
Citations
28
h-index
54
i10-index
Chaoqun Wang is an academic researcher from Qingdao University. The author has contributed to research in topics: RNA modifications and cancer & Cancer, Hypoxia, and Metabolism & Cancer-related gene regulation. The author has an h-index of 28, co-authored 119 publications.
ORCID: 0000-0001-9912-9477Papers by this author
worksEGFR conjunct FSCN1 as a Novel Therapeutic Strategy in Triple-Negative Breast Cancer
2017 · Scientific Reports · 45 citations
https://doi.org/10.1038/s41598-017-15939-9
Blueberry anthocyanins extract attenuated diabetic retinopathy by inhibiting endoplasmic reticulum stress via the miR-182/OGG1 axis
2022 · Journal of Pharmacological Sciences · 30 citations
https://doi.org/10.1016/j.jphs.2022.06.004
Impact of WNT1-inducible signaling pathway protein-1 (WISP-1) genetic polymorphisms and clinical aspects of breast cancer
2019 · Medicine · 25 citations
https://doi.org/10.1097/md.0000000000017854
Oncolytic virus M1 functions as a bifunctional checkpoint inhibitor to enhance the antitumor activity of DC vaccine
2023 · Cell Reports Medicine · 23 citations
https://doi.org/10.1016/j.xcrm.2023.101229
Regulation of tumor metastasis and CD8+ T cells infiltration by circRNF216/miR-576-5p/ZC3H12C axis in colorectal cancer
2024 · Cellular & Molecular Biology Letters · 16 citations
https://doi.org/10.1186/s11658-024-00539-z
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat